These are uncommon, affecting less than 1% of patients, but its important to be aware of them
For individuals seeking medically supervised weight management, there are several MHRA-approved options available in the UK that offer a robust evidence base and established safety profiles
Constipation : Affects approximately 324% of patients depending on the specific medication and dose, likely due to significantly slowed gastrointestinal transit time
A cost comparison of GLP-1 receptor agonists and bariatric surgery: What is the break even point
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al
Since a Retatrutide vial lasts you a month or more of weekly doses, bacteriostatic water is the right choice